IMU 4.26% 4.5¢ imugene limited

Ohio State University B-Vaxx Report, page-29

  1. 18 Posts.
    I don't think they are terrible(there are respondents and disease is stabilized well). There is good evidence in patients who showed anti tumor activity and no dose limitations/safety issues. However trail being limited to one center and there is still room for better selection of patients(the group is very heterogeneous) and they were heavily pre-treated and proper randomization is lacking. I believe with more centers and better clinical trail design and measurement, it will probably have more promising results.

    The reason I am buying huge shares of IMU is the the diversity of pipeline and amazing researchers. More over I like the B cell concept to be innovative.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.5¢
Change
-0.002(4.26%)
Mkt cap ! $386.7M
Open High Low Value Volume
4.7¢ 4.8¢ 4.4¢ $890.8K 19.42M

Buyers (Bids)

No. Vol. Price($)
2 176601 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 969572 8
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.